Genomic Health Announces Fourth Quarter and Year-End 2007 Financial Results and Business Progress and 2008 Financia...(6456 24625 General and ...),Health

General and

administrative 5,087 3,861 17,849 12,765

Total operating

expenses 26,096 18,025 93,689 60,139

Loss from operations (6,748) (9,409) (29,662) (30,965)

Other income (expense):

Interest and other income 900 548 3,048 2,491

Interest expense (143) (134) (678) (446)

Net loss ($5,991) ($8,995) ($27,292) ($28,920)

Basic and diluted net

loss per share ($0.21) ($0.37) ($1.02) ($1.18)

Shares used to

compute basic and

diluted net loss

per share 28,162,249 24,537,122 26,759,798 24,508,845

Genomic Health, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

As of As of

31-Dec-07 31-Dec-06

(Unaudited) (Audited)

Cash and cash equivalents $39,164 $14,926

Short-term investments 29,196 29,289

Accounts receivable, net 4,989 1,862

Prepaid expenses and other current assets 3,205 1,609

Total current assets 76,554 47,686

Property and equipment, net 10,412 9,421

Restricted cash 500 500

Other assets 463 417

Total assets $87,929 $58,024

Accounts payable $1,966 $2,523

Ac
'/>"/>